AsthmaVent - Effect of Mechanical Ventilation on Asthma Control in Children

Allergy Clinical Trial

— AsthmaVent  

Official title:

AsthmaVent - Effect of Mechanical Ventilation on Asthma Control in Children

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02068573
• Other study ID #: AstmaVen - 1101
• Status: Completed
• Phase: N/A
• First received: February 19, 2014
• Last updated: May 11, 2016
• Start date: August 2012
• Est. completion date: February 2016

Study information

• Verified date: May 2016
• Source: University of Aarhus
• Contact: n/a
• Is FDA regulated: No
• Health authority: Denmark: Danish Dataprotection Agency
• Study type: Interventional

Clinical Trial Summary

AsthmaVent is a multi-center study, investigating the association between indoor air quality and childhood asthma.

In Denmark, we spend more and more time indoors. Our houses are built airtight to save energy and are difficult to ventilate. We are thus more exposed to our indoor air than ever before. We know that indoor air contains many different components that can affect our airways inappropriately and particularly children with asthma, who have sensitive airways are sensitive to these components. The AsthmaVent project examines whether increased ventilation is able to improve the indoor environment to such an extent that the asthma disease control, for children with asthma and house dust mite allergy improves, resulting in need for less medication.

Previous studies have pointed towards a beneficial effect of mechanical ventilation, on both the indoor air quality and on children's health and quality of life. There is not currently a consensus in this area, as studies so far have not been large or good enough to confidently determine the effect.

This project is big and is designed so that it takes into account the sources of error seen in previous studies on the topic.

We include, over a 3-year period (2012-2014), a total of 80 children with asthma and house dust mite allergy aged 6-18 years, from pediatric departments in Aarhus, Odense, Kolding, Randers and Herning. They are divided into two groups, receiving either active ventilation or placebo ventilation, meaning a non-functioning ventilation system that just recirculates the air in the room. Ventilation systems are installed in the fall and winter and ventilate the child's bedroom during 9 months. Indoor air quality and asthma control are assessed every 3 months, both at home visits were air quality and allergen levels of house dust mites are studies and at visits to the outpatient clinics with control of asthma parameters and quality of life.

The project involves collaboration between several institutions with an interest in indoor air quality in relation to allergies and asthma and with great expertise in the field.The project was initiated by CISBO (Centre for Indoor Environment and Health in Dwellings), a center consisting of several institutions in Denmark dealing with indoor environment: Department of Public Health at Aarhus University and University of Copenhagen, Danish Building Research Institute and the Technical University of Denmark.

Since asthma is the most common chronic childhood disease in Denmark and since the development of allergies and asthma has high social and personal costs, it is important for both society and the individual family, to find out whether simply improving the indoor air quality by increased ventilation can lead to an improvement in asthma disease control.

Description:

The aim of the project is to investigate whether increased ventilation is able to improve the indoor air quality and thereby asthma disease control for children with asthma and house dust mite allergy.

Hypotheses:

1. An increased ventilation in the home will reduce the need for inhaled steroids in children with house dust mite allergy and asthma.

2. An increased ventilation in the home will improve the quality of life in children with house dust mite allergy and asthma.

3. An increased ventilation in the home will improve the indoor environment and thus improve asthma disease control in children with house dust mite allergy and asthma.

Materials and methods: The study is a randomized double-blind placebo-controlled intervention study. The intervention is balanced mechanical ventilation in the bedroom of children with asthma and house dust mite allergy during 9-months.

Population: Over 3 year period (2012-2014) 80 families with asthmatic children aged 6-18 years will be included from out-patient clinics at the children's department of the University Hospitals of Aarhus and Odense and regional hospitals in Kolding, Randers and Herning. Families will also be included from private pediatric clinics in Aarhus.

Randomization: After inclusion children are randomized to either active ventilation or placebo ventilation. Randomization is done in blocks of 4 by center.

Intervention: The ventilation units Type DUPLEX 370 EC4.D and DUPLEX 370 are installed during the fall and run continuously for 9 months. The ventilation system is placed outside the house and provides filtered conditioned air to the child's bedroom, through insulated pipes mounted in a window opening. The window opening was built specifically for this purpose in form of a thermo plate replacing the window glass. The unit provides the bedroom with at least 2-3 air changes per hour. The placebo unit (DUPLEX 370) is a completely similar installation which only recirculates the air in the room instead of replacing it. We recommend all parents to wash the duvet and pillow every 3 months.

Data collection:

Data on the children's health is collected every 3 months when the families visit the outpatient clinics. The children are seen by specialist doctors.

At home visits, also every 3 months, data concerning the indoor air quality is collected.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 46
• Est. completion date: February 2016
• Est. primary completion date: February 2016
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 5 Years to 18 Years

Eligibility

Inclusion Criteria:

• Doctors diagnosed asthma

• Need of inhaled steroid titrated down to at least 400 microg/day of Budesonide or equivalent dose of other corticosteroid

• Skin prick test >/= 3 mm or specific IgE >/= 0,7 kU/l to house dust mites (Derm. Pteronyssinus and/or Derm. Farinae)

• more than 500 nanog/gr dust of house dust mite allergen in the childs mattress.

• Living in a one-family house and will allow changes of the house during the intervention period.

• Capable of giving informed consent.

Exclusion Criteria:

• Other clinically relevant allergies to tree pollen or animals present in the house.

• Other diseases or treatments, as for example immunotherapy, which could influence the results.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Allergy
• Asthma
• Childhood Asthma

Intervention

Device:
• Ventilation
The ventilation system is placed outside the house and provides filtered conditioned air to the child's bedroom, through insulated pipes mounted in a window opening. The window opening was built specifically for this purpose in form of a thermo plate replacing the window glass. The unit provides the bedroom with at least 2-3 air changes per hour
• Placebo Ventilation
The placebo unit (DUPLEX 370) is a completely similar installation to the active ventilation unit, but it only recirculates the air in the room instead of replacing it with fresh conditioned air.

Locations

Country	Name	City	State
Denmark	Childrens Department, Aarhus University Hospital	Aarhus	Region Midt
Denmark	Børneafdelingen Herlev Hospital	Herlev	Region Hovedstaden
Denmark	Childrens Department, Herning Hospital	Herning	Region Midt
Denmark	Childrens Department, Hillerød hospital	Hillerød	Region Nordsjælland
Denmark	Childrens Department, Kolding Hospital	Kolding	Region Syddanmark
Denmark	H.C. Andersens Children Hospital, Odense University Hospital	Odense	Region Syddanmark
Denmark	Childrens DEpartment, Randers Hospital	Randers	Region Midt

Sponsors (1)

Lead Sponsor	Collaborator
University of Aarhus

Country where clinical trial is conducted

Denmark, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Changes in dose of inhaled corticosteroid	Measured in micrograms of a specific inhaled corticosteroid	Baseline, 3 months, 6 months and 9 months	No
Primary	Changes in particle concentration in child bedroom	Measured as particles pr. m3	baseline, 3 months, 6 months and 9 months	No
Secondary	FEV1	Forced Expiratory Volume after 1 second	Baseline, 3,6 and 9 months	No
Secondary	FeNO	Forced Expiratory Nitric Oxide	Baseline, 3,6 and 9 months	No
Secondary	Quality of Life	Pediatric Asthma Quality of Life Questionaire	Baseline, 3,6 and 9 months	No
Secondary	Standard Skin-prick-test and Specific IgE- phadiatop	Reduction in diameter of skin-prick-test for standard inhalant allergens and reduction in specific IgE for standard inhalant allergens measured in kU/l.	Baseline and 9 months	No
Secondary	Asthma Symptoms	Assessed from a Symptom score scheme	During 14 days at baseline, 3, 6 and 9 months	No
Secondary	Peakflow variability		Baseline, 3, 6 and 9 months	No
Secondary	Ventilation rate	Ventilation rate in the childs bedroom and in the Whole house	Baseline, 3, 6 and 9 months	No
Secondary	Physical conditions in the child bedroom and whole house	Changes in temperature and humidity	baseline, 3 6 and 9 months	No
Secondary	Allergens in child mattress and airborne in child bedroom	Reduction in allergen levels.	baseline, 3, 6 and 9 months	No